Β1-blockers lower norepinephrine release by inhibiting presynaptic, facilitating β1-adrenoceptors in normotensive and hypertensive rats

Frontiers in Neurology

Volumn 5 APR, Issue , 2014, Pages

  Berg, Torill ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Adrenal glands; Angiotensin II; Atenolol; Hypertension; Metoprolol; Norepinephrine release; adrenoceptors

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; LOSARTAN; METOPROLOL; NADOLOL; NORADRENALIN TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR RESPONSE; CATECHOLAMINE RELEASE; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; GANGLION; HEART WORK; HYPERTENSION; NERVE CONDUCTION; NONHUMAN; NORADRENALIN RELEASE; RAT; TACHYCARDIA; VASCULAR RESISTANCE;

EID: 84900986742     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2014.00051     Document Type: Article

References (33)

1. Adler-Graschinsky E, Langer SZ. Possible role of a beta-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism. Br J Pharmacol (1975) 53:43-50. doi:10.1111/j.1476-5381.1975.tb07328.x.
2. Nedergaard OA, Abrahamsen J. Modulation of noradrenaline release by activation of presynaptic beta-adrenoceptors in the cardiovascular system. Ann N Y Acad Sci (1990) 604:528-44. doi:10.1111/j.1749-6632.1990.tb32018.x.
3. Stjarne L, Brundin J. Beta2-adrenoceptors facilitating noradrenaline secretion from human vasoconstrictor nerves. Acta Physiol Scand (1976) 97:88-93. doi:10.1111/j.1748-1716.1976.tb10238.x.
4. Westfall TC, Peach MJ, Tittermary V. Enhancement of the electrically induced release of norepinephrine from the rat portal vein: mediation by beta 2-adrenoceptors. Eur J Pharmacol (1979) 58:67-74. doi:10.1016/0014-2999(79)90341-8.
5. Majewski H, Rand MJ, Tung LH. Activation of prejunctional beta-adrenoceptors in rat atria by adrenaline applied exogenously or released as a co-transmitter. Br J Pharmacol (1981) 73:669-79. doi:10.1111/j.1476-5381.1981.tb16802.x.
6. Berg T, Piercey BW, Jensen J. Role of beta1-3-adrenoceptors in blood pressure control at rest and during tyramine-induced norepinephrine release in spontaneously hypertensive rats. Hypertension (2010) 55:1224-30. doi:10.1161/HYPERTENSIONAHA.109.149286.
7. Murchison CF, Zhang XY, Zhang WP, Ouyang M, Lee A, Thomas SA. A distinct role for norepinephrine in memory retrieval. Cell (2004) 117:131-43. doi:10.1016/S0092-8674(04)00259-4.
8. Watson-Wright W, Boudreau G, Cardinal R, Armour JA. Beta 1-and beta 2-adrenoceptor subtypes in canine intrathoracic efferent sympathetic nervous system regulating the heart. Am J Physiol (1991) 261:R1269-75.
9. Berg T, Walaas SI, Roberg BA, Huynh TT, Jensen J. Plasma norepinephrine in hypertensive rats reflects alpha2-adrenoceptor release control only when re-uptake is inhibited. Front Neurol (2012) 3:160. doi:10.3389/fneur.2012.00160.
10. Berg T, Jensen J. Tyramine reveals failing alpha2-adrenoceptor control of catecholamine release and total peripheral vascular resistance in hypertensive rats. Front Neurol (2013) 4:19. doi:10.3389/fneur.2013.00019.
11. Berg T. Angiotensin AT1-alpha2C-adrenoceptor interaction disturbs alpha2A-autoinhibition of catecholamine release in hypertensive rats. Front Neurol (2013) 4:70. doi:10.3389/fneur.2013.00070.
12. Laflamme A, Oster L, Cardinal R, de Champlain J. Effects of renin-angiotensin blockade on sympathetic reactivity and beta-adrenergic pathway in the spontaneously hypertensive rat. Hypertension (1997) 30:278-87. doi:10.1161/01.HYP.30.2.278.
13. Majewski H. Angiotensin II and noradrenergic transmission in the pithed rat. J Cardiovasc Pharmacol (1989) 14:622-30. doi:10.1097/00005344-198910000-00014.
14. Yarova PL, Smirnov SV, Dora KA, Garland CJ. beta1-Adrenoceptor stimulation suppresses endothelial IKCa-channel hyperpolarization and associated dilatation in resistance arteries. Br J Pharmacol (2013) 169:875-86. doi:10.1111/bph.12160.
15. Mandela P, Ordway GA. The norepinephrine transporter and its regulation. J Neurochem (2006) 97:310-33. doi:10.1111/j.1471-4159.2006.03717.x.
16. Berg T. Increased counteracting effect of eNOS and nNOS on an alpha1-adrenergic rise in total peripheral vascular resistance in spontaneous hypertensive rats. Cardiovasc Res (2005) 67:736-44. doi:10.1016/j.cardiores.2005.04.006.
17. Jezova D, Ochedalski T, Kiss A, Aguilera G. Brain angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocortical activation during stress. J Neuroendocrinol (1998) 10:67-72. doi:10.1046/j.1365-2826.1998.00182.x.
18. Berg T, Jensen J. Simultaneous parasympathetic and sympathetic activation reveals altered autonomic control of heart rate, vascular tension, and epinephrine release in anesthetized hypertensive rats. Front Neurol (2011) 2:71. doi:10.3389/fneur.2011.00071.
19. Starke K, Gothert M, Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev (1989) 69:864-989.
20. Li CG, Majewski H, Rand MJ. Facilitation of noradrenaline release from sympathetic nerves in rat anococcygeus muscle by activation of prejunctional beta-adrenoceptors and angiotensin receptors. Br J Pharmacol (1988) 95:385-92. doi:10.1111/j.1476-5381.1988.tb11657.x.
21. Milavec-Krizman M, Evenou JP, Wagner H, Berthold R, Stoll AP. Characterization of beta-adrenoceptor subtypes in rat kidney with new highly selective beta 1 blockers and their role in renin release. Biochem Pharmacol (1985) 34:3951-7. doi:10.1016/0006-2952(85)90371-5.
22. Teschemacher AG, Seward EP. Bidirectional modulation of exocytosis by angiotensin II involves multiple G-protein-regulated transduction pathways in chromaffin cells. J Neurosci (2000) 20(13):4776-85.
23. Todorov L, Windisch K, Shersen H, Lajtha A, Papasova M, Vizi ES. Prejunctional nicotinic receptors involved in facilitation of stimulation-evoked noradrenaline release from the vas deferens of the guinea-pig. Br J Pharmacol (1991) 102:186-90. doi:10.1111/j.1476-5381.1991.tb12151.x.
24. Schmidt HH, Schurr C, Hedler L, Majewski H. Local modulation of noradrenaline release in vivo: presynaptic beta 2-adrenoceptors and endogenous adrenaline. J Cardiovasc Pharmacol (1984) 6:641-9. doi:10.1097/00005344-198407000-00014.
25. Murugaiah KD, O'Donnell JM. Facilitation of noradrenaline release from rat brain slices by beta-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol (1995) 351:483-90. doi:10.1007/BF00171039.
26. Clarke GL, Bhattacherjee A, Tague SE, Hasan W, Smith PG. Beta-adrenoceptor blockers increase cardiac sympathetic innervation by inhibiting autoreceptor suppression of axon growth. J Neurosci (2010) 30:12446-54. doi:10.1523/JNEUROSCI.1667-10.2010.
27. Sala F, Nistri A, Criado M. Nicotinic acetylcholine receptors of adrenal chromaffin cells. Acta Physiol (2008) 192:203-12. doi:10.1111/j.1748-1716.2007.01804.x.
28. Kopp UC, Jones SY, Dibona GF. Afferent renal denervation impairs baroreflex control of efferent renal sympathetic nerve activity. Am J Physiol (2008) 295:R1882-90. doi:10.1152/ajpregu.90529.2008.
29. Kopp UC, Smith LA, Dibona GF. Impaired renorenal reflexes in spontaneously hypertensive rats. Hypertension (1987) 9:69-75. doi:10.1161/01.HYP.9.1.69.
30. Esler M, Kaye D. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol (2000) 35:S1-7. doi:10.1097/00005344-200000004-00001.
31. Man in't Veld AJ, Schalekamp MA. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension. Postgrad Med J (1983) 59(Suppl 3):140-58.
32. Schomig A, Richardt G, Kurz T. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact. Herz (1995) 20:169-86.
33. Bonet S, Agusti A, Arnau JM, Vidal X, Diogene E, Galve E, et al. Beta-adrenergic blocking agents in heart failure: benefits of vasodilating and non-vasodilating agents according to patients' characteristics: a meta-analysis of clinical trials. Arch Intern Med (2000) 160:621-7. doi:10.1001/archinte.160.5.621.